BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10203593)

  • 1. Expression of Mad1 protein inhibits proliferation of cancer cells and inversely correlated with Myc protein expression in primary gastric cancer.
    Han S; Park K; Kim HY; Lee MS; Kim HJ; Kim YD
    Oncol Rep; 1999; 6(3):569-74. PubMed ID: 10203593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of altered expression of Mad1 protein in human breast carcinoma.
    Han S; Park K; Kim HY; Lee MS; Kim HJ; Kim YD; Yuh YJ; Kim SR; Suh HS
    Cancer; 2000 Apr; 88(7):1623-32. PubMed ID: 10738221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1.
    Bejarano MT; Albihn A; Cornvik T; Brijker SO; Asker C; Osorio LM; Henriksson M
    Exp Cell Res; 2000 Oct; 260(1):61-72. PubMed ID: 11010811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis.
    Dey A; Kim L; Li W
    J Cell Biochem; 1999 Feb; 72(2):232-41. PubMed ID: 10022505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
    Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
    Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.
    Werner S; Beer HD; Mauch C; Lüscher B; Werner S
    Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts.
    Hultquist A; Cetinkaya C; Wu S; Castell A; Erlandsson A; Larsson LG
    Mol Cancer Res; 2004 Aug; 2(8):464-76. PubMed ID: 15328373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-induction of Mad1 and c-Myc in activated normal B lymphocytes.
    Ertesvåg A; Blomhoff HK; Beiske K; Naderi S
    Scand J Immunol; 2000 Jun; 51(6):565-70. PubMed ID: 10849366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
    Zou L; Zhang P; Luo C; Tu Z
    Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27kip1-independent cell cycle regulation by MYC.
    Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
    Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanistic study of cigarette smoke and cyclooxygenase-2 on proliferation of gastric cancer cells.
    Shin VY; Liu ES; Ye YN; Koo MW; Chu KM; Cho CH
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):103-12. PubMed ID: 14962510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell proliferation by the Mad1 transcriptional repressor.
    Roussel MF; Ashmun RA; Sherr CJ; Eisenman RN; Ayer DE
    Mol Cell Biol; 1996 Jun; 16(6):2796-801. PubMed ID: 8649388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAD1 and its life as a MYC antagonist: an update.
    Lüscher B
    Eur J Cell Biol; 2012; 91(6-7):506-14. PubMed ID: 21917351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.
    Leoncini L; Bellan C; Cossu A; Claudio PP; Lazzi S; Cinti C; Cevenini G; Megha T; Laurini L; Luzi P; Orcioni GF; Piccioli M; Pileri S; Giardino C; Tosi P; Giordano A
    Clin Cancer Res; 1999 Dec; 5(12):4065-72. PubMed ID: 10632341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mad1 is a transcriptional repressor of Bcl-6.
    Lee SC; Bottaro A; Chen L; Insel RA
    Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
    Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
    Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of C-Myc mRNA in squamous cell carcinoma of the tongue.
    Vora HH; Shah NG; Trivedi TI; Goswami JV; Shukla SN; Shah PM
    J Surg Oncol; 2007 Jan; 95(1):70-8. PubMed ID: 17192869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.